1. "Body Imaging Service"
Formats
  1. Journal Article (1718)
  2. Meeting Abstract (519)
  3. Review (163)
  4. Book Section (128)
  5. Conference Paper (43)
  6. Editorial (35)
  7. Guidelines (29)
  8. Miscellaneous (16)
  9. Correspondence (11)
  10. Book Whole (5)
  11. Research Letter (4)
Groups
  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)

More Groups

People
  1. Lawrence Schwartz (306)
  2. Oguz Akin (264)
  3. Kinh Gian Do (256)
  4. Michelle Ginsberg (235)
  5. Marc Gollub (208)
  6. Hedvig Hricak (158)

More People

Years
  1. 2025 (69)
  2. 2024 (169)
  3. 2023 (220)
  4. 2022 (200)
  5. 2021 (189)
  6. 2020 (165)

More Years

Publications
  1. Journal of Clinical Oncology (322)
  2. American Journal of Roentgenology (147)
  3. Radiology (122)
  4. Abdominal Radiology (84)
  5. European Radiology (67)
  6. Clinical Cancer Research (65)

More Publications

Publishers
  1. Springer (359)
  2. American Society of Clinical Oncology (346)
  3. Elsevier Inc. (316)
  4. American Roentgen Ray Society (147)
  5. Radiological Society of North America, Inc. (141)
  6. Elsevier Science, Inc. (128)

More Publishers

Results (2671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot study of NKTR214 and nivolumab in patients with sarcomas
    Meeting Abstract

    D'Angelo, S. P.; Conley, A. P.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Keohan, M. L.; Livingston, J. A.; Patel, S.; Adamson, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and a PD-L1 tumor proportion score ≥90%
    Meeting Abstract

    Jimenez Aguilar, E.; Ricciuti, B.; Gainor, J. F.; Nishino, M.; Adeni, A. E.; Subegdjo, S.; Khosrowjerdi, S.; Peterson, R.; Digumarthy, S.; Liu, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Mechanisms underlying the association between sarcopenia and poor oncologic outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Sanchez, A.; Kuo, F.; Petruzella, S.; Akin, O.; Paris, M.; Russo, P.; Chan, T. A. T.; Mourtzakis, M.; Hakimi, A. A.; Furber, H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
    Meeting Abstract

    Shah, A. Y.; Kotecha, R.; Lemke, E.; Chandramohan, A.; Chaim, J.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M. T.; Zurita, A. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of ADI-PEG 20 and FOLFOX6 in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Qin, S.; Yang, T. S.; Yen, C. J.; Chao, Y.; Wang, T. E.; Do, R. K. G.; El Dika, I. H.; Uhlitskykh, K.; Millang, B. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer: NRG-GI002
    Meeting Abstract

    George, T. J.; Yothers, G.; Rahma, O. E.; Hong, T. S.; Russell, M. M.; You, Y. N.; Parker, W.; Jacobs, S. A.; Lucas, P. C.; Gollub, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its interaction with NF1
    Meeting Abstract

    Su, W.; Yaeger, R.; Na, N.; Hechtman, J.; Paroder, V.; Misale, S.; Han, S. W.; Abdel-Wahab, O. I.; McCormick, F.; Rosen, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save